Abstract 1106
Background
Prolonged grief disorder (PGD) and depression are common emotional disorders influencing bereaved caregivers’ quality of life (QOL). However, the conceptual distinctiveness and temporal relationship of PGD and depression have been partially and not established, respectively. To fill these knowledge gaps, we conducted this longitudinal study.
Methods
Our convenience sample included 291 caregivers of terminally ill cancer patients. Caregivers’ PGD, depression, and psychological QOL were measured 6, 13, 18, and 24 months postloss using the Prolonged Grief-13 scale (PG-13), Center for Epidemiologic Studies-Depression (CESD) scale, and Short Form-36 Health Survey mental health summary, respectively. We examined the associations of PGD and depression with psychological QOL by an incremental validity test, thereby clarifying their conceptual distinctiveness. The temporal relationship between PGD and depression was examined by longitudinal, lower-level mediation analysis with a lagged approach.
Results
After the variance in psychological QOL was significantly explained by CESD scores (pseudo R2=44.19%, p<.001), PGD significantly, incrementally increased the explained variance in psychological QOL (pseudo R2=.21%, p<.001), confirming the distinction between PGD and depression. Lower-level mediation analysis showed that CESD scores (depressive symptoms) mediated 90% of the relationship between time and PG-13 scores, whereas PG-13 scores only mediated 76% of the relationship between time and CESD scores. This result indicates that CESD scores assessed at a previous time mediated caregivers’ current PGD during bereavement rather than vice versa.
Conclusions
PGD and depression are conceptually distinct disorders, and depression precedes development of PGD. Clinicians must distinguish between the two disorders and appropriately manage bereaved caregivers’ depressive symptoms. Alleviating caregivers’ depressive symptoms will prevent development of PGD, thus improving QOL.
Clinical trial identification
(NHRI-EX107-10704PI) and Ministry of Science and Technology (MOST 104-2314-B-182-027-MY3), National Science Council (NSC 96-2314-B-182-029-MY2), and Chang Gung Memorial Hospital (BMRP888).
Legal entity responsible for the study
Chang Gung University.
Funding
Ministry of Science and Technology, National Science Council, and Chang Gung Memorial Hospital.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2595 - Real-Life Utilization of Genomic testing for invasive Breast Cancer patients in Italy and France reduces Chemotherapy Recommendations
Presenter: Sandro Barni
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2343 - Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast
Presenter: Alexandre De Nonneville
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2990 - Baseline lymphocyte counts predict distant recurrence in early breast cancer
Presenter: Gun Min Kim
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
4532 - A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure Invasive Lobular Breast Carcinoma (ILC).
Presenter: Luisa Carbognin
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2344 - Benefit of Adjuvant Systemic Therapies in HR+ HER2- pT1ab Node-Negative Breast Carcinomas
Presenter: Alexandre De Nonneville
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
3525 - Anti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): an open-label, randomized, three-arm, multicenter, window-of-opportunity study
Presenter: Aleix Prat
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
3908 - Clinicopathologic significance of androgen receptor expression and discordant receptor status during progression in breast cancer
Presenter: Chan Heun Park
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
4075 - The outcomes of early breast cancers utilizing the Oncotype Dx Recurrence score (RS) instead of Clinico-pathological (CP) factors for prognostic risk assessment: A Single Institution Experience
Presenter: Adhar Alsayed
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
738 - Circulating tumor cells as a prognostic marker in non metastatic breast cancer patients.
Presenter: Summar Elmorshidy
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
3151 - Molecular subtyping of breast cancer by dedicated breast PET
Presenter: Satoshi Sueoka
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract